Release of peptide YY and inhibition of gastric acid secretion by long‐chain and medium‐chain triglycerides but not by sucrose polyester in men

No abstract is available for this paper.

• Publication year

  1998

• Venue

  European Journal of Clinical Investigation

• Publication date

  1998-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1046/j.1365-2362.1998.00255.xPMID 9541126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sucrose polyester does not inhibit gastric acid secretion or stimulate cholecystokinin release in men.

  1997cited by this paper
• Plasma PYY in response to intraduodenal amino acids with or without cholestyramine; role of cholecystokin

  1996cited by this paper
• Regulation of peptide YY homeostasis by gastric acid and gastrin.

  1996cited by this paper
• Inhibition of gastrin-stimulated gastric acid secretion by medium-chain triglycerides and long-chain triglycerides in healthy young men.

  1996cited by this paper
• Statistics notes: Calculating correlation coefficients with repeated observations: Part 1—correlation within subjects

  1995cited by this paper
• Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects.

  1995cited by this paper
• Nitric oxide in gastroprotective and ulcer healing effects of sucralfate.

  1995cited by this paper
• Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients.

  1995cited by this paper
• Ileal release of glucagon-like peptide-1 (GLP-1)

  1995cited by this paper
• Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans.

  1994cited by this paper
• Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36.

  1994cited by this paper
• Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.

  1994cited by this paper
• Effect of loxiglumide on basal and gastrin- and bombesin-stimulated gastric acid and serum gastrin levels.

  1992cited by this paper
• A physiological role for cholecystokinin as a regulator of gastrin secretion.

  1992cited by this paper
• Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats.

  1992cited by this paper
• AMP deaminase binding in contracting rat skeletal muscle.

  1992cited by this paper
• Gastric emptying and intragastric distribution of oil in the presence of a liquid or a solid meal.

  1992cited by this paper
• Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.

  1992cited by this paper
• Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion.

  1992cited by this paper
• Effect of a purified somatostatin monoclonal antibody and its Fab fragments on gastrin release.

  1991cited by this paper
• The effect of SMS 201-995 on meal and CCK-stimulated peptide YY release.

  1991cited by this paper
• Intracolonic fat inhibits gastric acid secretion independent of gastrin release in the dog

  1991cited by this paper
• Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man.

  1990cited by this paper
• Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.

  1990cited by this paper
• Inhibition of human gastric acid secretion by peptide YY and secretin.

  1990cited by this paper
• Linkage between somatostatin and acid secretion: evidence from use of pertussis toxin.

  1989cited by this paper
• Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog.

  1989cited by this paper
• Evidence for regulation of peptide-YY release by the proximal gut.

  1989cited by this paper
• Inhibitory effect of peptide YY on gastric acid output in rats.

  1989cited by this paper
• Inhibition of Gastric Acid Secretion by Peptide YY Is Independent of Gastric Somatostatin Release in the Rat 1

  1988cited by this paper
• Paracrine regulation of gastric acid secretion by fundic somatostatin.

  1987cited by this paper
• Effects of monoclonal antibodies to somatostatin on somatostatin-induced and intestinal fat-induced inhibition of gastric acid secretion in the rat.

  1987cited by this paper
• Regulation of gastric acid secretion by neurotensin in man. Evidence against a hormonal role.

  1987cited by this paper
• Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin.

  1987cited by this paper
• Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.

  1987cited by this paper
• Inhibitory action of peptide YY on gastric acid secretion.

  1987cited by this paper
• Enterogastrone-like effect of peptide YY is vagally mediated in the dog.

  1986cited by this paper
• Multiple test procedures for arbitrary dependence structures

  1986cited by this paper
• Regional distribution and release of peptide YY with fatty acids of different chain length.

  1985cited by this paper
• Peptide YY inhibits meal-stimulated pancreatic and gastric secretion.

  1985cited by this paper
• Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

  1985cited by this paper
• Human distribution and release of a putative new gut hormone, peptide YY.

  1985cited by this paper
• Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.

  1984cited by this paper
• Role of endogenous secretin in acid-induced inhibition of human gastric function.

  1984cited by this paper
• Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction.

  1984cited by this paper
• Response of gastric inhibitory polypeptide to fat ingestion in normal dogs.

  1984cited by this paper
• Radioimmunoassay of Cholecystokinin: Production and Evaluation of Antibodies

  1983cited by this paper
• Serum gastrin responses to bombesin and food in patients with hypergastrinemia

  1982cited by this paper
• Somatostatin-14 and -28: clearance and potency on gastric function in dogs.

  1982cited by this paper
• Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.

  1982cited by this paper
• Mobilization of a common source of smooth muscle Ca2+ by norepinephrine and methylxanthines.

  1981cited by this paper
• Role of secretin on postprandial gastrin release in the dog: a further study.

  1981cited by this paper
• Secretin is an enterogastrone in the dog.

  1981cited by this paper
• A possible relation between the regulation of gastric emptying and food intake.

  1980cited by this paper
• Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man

  1980cited by this paper
• Intestinal electrophysiology and transmural ion transport in freshwater prawns.

  1980cited by this paper
• Secretin is an enterogastrone in dog

  1980cited by this paper
• Isolation of viral IgY antibodies from yolks of immunized hens.

  1980cited by this paper
• Effect of ninety-five percent pure cholecystokinin on gastrin-stimulated acid secretion in man and dog.

  1979cited by this paper
• Energy density of food, gastric emptying, and obesity.

  1978cited by this paper
• An Approximate Analysis of Variance Test for Normality

  1972cited by this paper
• Positioning of Subject and of Nasogastric Tube during a Gastric Secretion Study

  1970cited by this paper
• Demonstration of the Humoral Agent in Fat Inhibition of Gastric Secretion.

  1930cited by this paper

• Fat Amount Rather Than Fatty Acid Composition Influences Postprandial Hunger, Satiety and Attention in Men and Women with a Risk Phenotype for Cardiometabolic Diseases: A Randomized Crossover Trial

  2025cites this paper
• Comparing acute effects of extra virgin coconut oil and extra virgin olive oil consumption on appetite and food intake in normal-weight and obese male subjects

  2022cites this paper
• Dietary conjugated linoleic acid and medium-chain triglycerides for obesity management

  2021cites this paper
• Dietary conjugated linoleic acid and medium-chain triglycerides for obesity management

  2021cites this paper
• A comparison of the satiating properties of medium-chain triglycerides and conjugated linoleic acid in participants with healthy weight and overweight or obesity

  2020cites this paper
• Dietary lipids with potential to affect satiety: Mechanisms and evidence

  2019cites this paper
• Maternal intake of dietary virgin coconut oil modifies essential fatty acids and causes low body weight and spiky fur in mice

  2017cites this paper
• Lack of Effects of a Single High-Fat Meal Enriched with Vegetable n-3 or a Combination of Vegetable and Marine n-3 Fatty Acids on Intestinal Peptide Release and Adipokines in Healthy Female Subjects

  2016cites this paper
• Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight men

  2014cites this paper
• The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism

  2013cites this paper
• Hepatic Lipid Metabolism , NAFLD , and Gut Peptides in the Era of Metabolic Syndrome

  2013cites this paper
• [Foods and nutrients modulates the release of anorexigenic gastrointestinal hormones].

  2010cites this paper
• Fats and Satiety

  2010cites this paper
• Satiety, weight management and foods : literature review

  2009cites this paper
• Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans.

  2008cites this paper
• 14 – Medium-chain and structured triglycerides: their role in weight control

  2007cites this paper
• The effects of dairy components on food intake and satiety.

  2007cites this paper
• Hunger and satiety : relation to body weight control

  2007cites this paper
• Metabolically active functional food ingredients for weight control

  2006cites this paper
• Milk proteins in food-food and food-drug synergy on feeding behavior, energy balance, and body weight regulation.

  2006cites this paper
• Gut Hormone Profiles in Critically Ill Neonates on Extracorporeal Membrane Oxygenation

  2005influential citation
• Developments in the inhibition of gastric acid secretion

  2005cites this paper
• Short and Long Term Studies in Neonates treated with Extracorporeal Membrane Oxygenation (ECMO)

  2005cites this paper
• Regulation of food intake : a focus on ghrelin

  2005cites this paper
• 4 Nutrients as regulators of endocrine and neuroendocrine secretion

  2004cites this paper
• Satiety and the control of obesity

  2004cites this paper
• Biomarkers of satiation and satiety.

  2004cites this paper
• Biomarkers of satiation and satiety 1,2

  2004cites this paper
• Peptide YY release after colectomy in slow transit constipation

  2004cites this paper
• Gastrointestinal hormone secretion after surgery in neonates with congenital intestinal anomalies during starvation and introduction of enteral nutrition.

  2003cites this paper
• Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra.

  2003cites this paper
• Gut Hormones in Preterm Infants With Necrotizing Enterocolitis During Starvation and Reintroduction of Enteral Nutrition

  2002cites this paper
• Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity.

  2002cites this paper
• Basal and Fat-Stimulated Plasma Peptide YY Levels in Celiac Disease

  2001cites this paper
• Effect of circulating peptide YY on gallbladder emptying in humans.

  2001cites this paper
• Effect of Circulating Peptide YY on Gallbladder Emptying in Humans

  2001cites this paper
• Role of Circulating Peptide YY in the Inhibition of Gastric Acid Secretion by Dietary Fat in Humans

  2000cites this paper
• Role of circulating peptide YY in the inhibition of gastric acid secretion by dietary fat in humans.

  2000cites this paper
• Effects of fat and carbohydrate meals on colonic motor response

  2000cites this paper
• Effect of rectal distension on gallbladder emptying and circulating gut hormones

  2000cites this paper
• Plasma Cholecystokinin, Plasma Peptide YY and Gallbladder Motility in Patients with Slow Transit Constipation: Effect of Intestinal Stimulation

  2000influential citation
• Effect of medium- and long-chain triglycerides on lower esophageal sphincter pressure: role of CCK.

  1998cites this paper
• Effect of medium- and long-chain triglycerides on lower esophageal sphincter pressure: role of CCK.

  1998cites this paper